未登录

S

Sandrine Valsesia-Wittmann

unicancer

H指数:21

被引数:3,677

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Antibody and antibody fragments site-specific conjugation using new Q-tag substrate of bacterial transglutaminase

CELL DEATH DISCOVERY

IF7

2024-02-157

OAAI

Repurposing infectious disease vaccines for intratumoral immunotherapy

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2020-02-2519

OAAI

Repurposing rotavirus vaccines for intratumoral immunotherapy can overcome resistance to immune checkpoint blockade

SCIENCE TRANSLATIONAL MEDICINE

IF14.6

2019-10-2351

OAAI

Cold Tumors: A Therapeutic Challenge for Immunotherapy

冷肿瘤: 免疫治疗的治疗挑战

FRONTIERS IN IMMUNOLOGY

IF5.9

2019-02-08876

OAAI

CovisoLinK: New bacterial transglutaminase Q-Tag substrate for the development of site specific antibody-drug conjugates

CANCER RESEARCH

IF16.6

2018-07-010

PRE

Immunostimulatory and oncolytic properties of rotavirus can overcome resistance to immune checkpoint blockade therapy

CANCER RESEARCH

IF16.6

2018-07-010

PRE

Pattern recognition receptors: immune targets to enhance cancer immunotherapy

模式识别受体: 增强癌症免疫治疗的免疫靶点

ANNALS OF ONCOLOGY

IF65.4

2017-08-01133

OAAI

Adipose cells promote resistance of breast cancer cells to trastuzumab-mediated antibody-dependent cellular cytotoxicity

BREAST CANCER RESEARCH

IF5.6

2015-04-2495

OAAI

Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients

Science Translational Medicine

IF14.6

2015-04-1584

PREAI

Semeraro, Michaela; Rusakiewicz, Sylvie; Minard-Colin, Veronique; Delahaye, Nicolas F.; Enot, David; Vely, Frederic; Marabelle, Aurelien; Papoular, Benjamin; Piperoglou, Christelle; Ponzoni, Mirco; Perri, Patrizia; Tchirkov, Andrei; Matta, Jessica; Lapierre, Valerie; Shekarian, Tala; Valsesia-Wittmann, Sandrine; Commo, Frederic; Prada, Nicole; Poirier-Colame, Vichnou; Bressac, Brigitte; Cotteret, Sophie; Brugieres, Laurence; Farace, Francoise; Chaput, Nathalie; Kroemer, Guido; Valteau-Couanet, Dominique; Zitvogel, Laurence

TWIST1 is a direct transcriptional target of MYCN and MYC in neuroblastoma

IF10.1

2015-02-0142

PREAI

Effect of kinase inhibitors on the therapeutic properties of monoclonal antibodies

IF7.3

2015-01-1425

OAAI

In Vitro and In Vivo Comparison of Lymphocytes Transduced with a Human CD16 or with a Chimeric Antigen Receptor Reveals Potential Off-Target Interactions due to the IgG2 CH2-CH3 CAR-Spacer

JOURNAL OF IMMUNOLOGY RESEARCH

IF3.6

2015-01-0126

OAAI

Adipocytes inhibit trastuzumab-mediated ADCC via induction of GDF15

CANCER RESEARCH

IF16.6

2014-10-010

PRE

Overcoming therapeutic MAb resistance in agressive HER2-positive breast carcinomas by adoptive immunotherapy using optizimed effectors cells.

CANCER RESEARCH

IF16.6

2014-04-020

PRE

Comparing genetically engineered T cells for chimeric TCR versus CD16+Herceptin for adoptive immunotherapy against HER2 positive breast carcinomas

CANCER RESEARCH

IF16.6

2011-04-010

PRE

Mutant p53R175H upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells

CELL DEATH AND DIFFERENTIATION

IF15.4

2010-08-06150

OAAI

Upstream ORF affects MYCN translation depending on exon 1b alternative splicing

IF3.4

2009-12-1710

OAAI

Cancer Stem Cells: The Emerging Challenge of Drug Targeting

CURRENT MEDICINAL CHEMISTRY

IF3.5

2009-02-0161

PREAI

A twist for survival and cancer progression

BRITISH JOURNAL OF CANCER

IF6.8

2005-11-22215

OAAI

Genome-wide analysis of gene expression in neuroblastomas detected by mass screening

IF10.1

2005-07-0140

OAAI